Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial. - Wikidata - thesis-toulmin - TriplyDB

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

http://www.wikidata.org/entity/Q30840447

about

Diabetes Drugs and Cardiovascular Safety The EMPA-REG outcome study: critical appraisal and potential clinical implications Polypharmacy in the Aging Patient: A Review of Glycemic Control in Older Adults With Type 2 Diabetes Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease.Relationship of glycaemic control and hypoglycaemic episodes to 4-year cardiovascular outcomes in people with type 2 diabetes starting insulin Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes.Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart.A Link Between Hypoglycemia and Progression of Atherosclerosis in the Veterans Affairs Diabetes Trial (VADT).Prostanoids and NSAIDs in cardiovascular biology and disease.Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.Emerging use of combination therapies for the management of type 2 diabetes - focus on saxagliptin and dapagliflozin.Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study.Near normal HbA1c with stable glucose homeostasis: the ultimate target/aim of diabetes therapy.Intensive Glycemic Control in Cardiac Surgery.Glucose targets for preventing diabetic kidney disease and its progression.Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers.Considerations on glycaemic control in older and/or frail individuals with diabetes and advanced kidney disease.Genetically Driven Hyperglycemia Increases Risk of Coronary Artery Disease Separately From Type 2 Diabetes.Diabetes management in older people: a focus on cardiovascular risk reduction.The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study.Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.Cardio-Metabolic Benefits of Plant-Based Diets.Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.Metformin protects against oxidized low density lipoprotein-induced macrophage apoptosis and inhibits lipid uptake.Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes.Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease.Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.Cost Calculation for a Flash Glucose Monitoring System for Adults with Type 2 Diabetes Mellitus Using Intensive Insulin - a UK Perspective Development of a model to predict 5-year risk of severe hypoglycemia in patients with type 2 diabetes

P2860

Q26746085-5832F061-6456-46A3-9ED6-0594A8C39250 Q26748742-82C1311B-64A8-456C-912C-6A221EE2ABCC Q26767283-F3433FA0-CD15-45BB-A9CE-B51819FDC691 Q35594537-66C51095-ED9D-4138-A8AD-8A05E452FA58 Q35692664-ED1CA0B6-3729-457D-A96B-1FE5704D26CC Q36536863-34A72E0B-840C-4C36-BB6A-A09E627249FF Q36820609-F984B467-F931-405A-B8BC-E1E594B44299 Q36930826-101A79AB-9FB4-423F-962C-3F156B1E701B Q36935362-53C1587D-B214-4C12-A0B6-7D5B2ABF3653 Q37107072-6B5D251E-9864-4215-8315-85BE4D286F7C Q37652806-07B39EC3-895C-467F-A78F-DF4ECD1DB4BB Q38504675-923006A9-48E9-47A7-A9E6-49B8706BDBBF Q38524435-A0137DAB-FA62-4A69-B057-7BF25D500BFE Q38645792-C1525D8B-4FEE-4013-A9F4-EA77878F60D1 Q38650417-372CCF58-45C8-4769-8087-B9F00C4DD4D7 Q38709204-1BB468E2-D8FD-4B6F-9AF0-F2332BFFC9A7 Q38734505-C60D7D40-2EF6-44C6-9240-9AB17F5AFBF6 Q38736800-8F670AAE-D584-42DB-A87C-9394FEB3AAD9 Q38755607-3C0272E4-99A3-41CB-9FC7-6FC6DF5DE526 Q38878430-C8B1B6F1-7E38-4153-82CE-E08A9A946A89 Q38905127-8A52039A-F8D5-4364-8B39-D0E25D5AC668 Q38977597-C0414F77-1D96-48F5-B578-A45ACC135EF8 Q40049090-7CAD8D8B-329F-488E-B792-CAB08EDCD0DF Q40385682-DA209D65-09A7-4208-B5A9-97CE221ACCDC Q40758518-F8D5B700-0C57-48BB-BED2-6656E60FF536 Q41584066-F9EBBE79-7288-41A5-945E-91ED9A751540 Q47868741-DF977BD9-DEE7-40FC-92FE-EE3CE84B69E3 Q49884416-EE891F5D-BDF6-47DA-BA8D-89E5450918D6 Q50053976-38DFD35C-7EDE-4470-A4A8-394DFA423641 Q51305542-C421F148-2F08-43DD-99FE-84E9799514F7 Q55414915-D713868B-6359-4290-BB7D-2486FA67669E Q57822718-D60D54A8-5C3A-4D38-8374-9D6C936C4B87 Q58787950-F98040DC-FCB7-4463-B5D3-08E5A3396B52

P2860

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

http://www.wikidata.org/entity/Q30840447

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@ast

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@en

type

label

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@ast

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@en

prefLabel

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@ast

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@en

P1433

Q30840447-00EDBAD7-BF91-4124-AAC6-BCBB6EFC19C4

P1476

Q30840447-A0C0E1B2-0F83-44D0-9A12-48D70383201B

P2093

Q30840447-1DCBFFA2-19CB-4C48-8FDF-50AD10B49F6C

Q30840447-670A3708-41C4-4B34-81BF-47E91497AC11

Q30840447-7CEC52C7-3BE2-45CB-9462-81E34B54CB30

Q30840447-93A20A02-C125-43DB-AF92-83E7BE84D16D

Q30840447-D054037E-BF07-4FD4-87D2-BE5D64DBB6C1

Q30840447-EF333FD0-04D1-4127-A6EE-12C82011FB18

P2860

Q30840447-0B6719C6-5F89-496E-926B-089D34C30142

Q30840447-3E9E7EDB-1F90-4FD4-8054-DA949E515D1C

Q30840447-72DBB964-EEE0-4565-B01D-CF7E152912BA

Q30840447-792C6915-A8E1-49DD-B9E2-FD0199EC8BD6

Q30840447-7C4DA526-F4E4-447D-86E3-A35B14D14859

Q30840447-923727E1-6E30-4808-9E26-F54AB32B7AF9

Q30840447-9439A200-D8FE-4789-B9E4-E98CFFF2CA4F

Q30840447-99D9CDF2-25E1-425E-91C5-78FFE8F722DE

Q30840447-A0A7951B-19BC-487D-84D7-0A5A98CC8A68

Q30840447-A16163CE-425F-4319-866B-25D35C2AF8D2

P304

Q30840447-2357B31D-2756-45BA-994A-59D5DD47F97C

P31

Q30840447-4FA0AEA3-1A3F-4992-8F9D-E79FFEFA6E26

P356

Q30840447-ABEDD4E3-B0AC-4D15-A765-8EFCD92DF7E8

P407

Q30840447-E50158A6-CC30-4BAE-AF02-C5B39C7CCEC9

P433

Q30840447-A4CF79FD-C135-4AF1-9D64-B9AD8493BA91

P478

Q30840447-125E96B3-C03F-4597-9CF5-59556E606206

P50

Q30840447-27875BCC-6F0B-4D29-9EC9-2F7CB205D58F

Q30840447-9AB27577-28D9-4ED3-92B9-711B2B90BD93

P577

Q30840447-31FB93EE-91E8-4804-9C93-1BD5702B7A69

P698

Q30840447-3588F9FB-3532-4573-A059-2DC06056E1A3

P932

Q30840447-3E65AB02-0DC9-4519-A11C-52F6EC9B101D

P356

S0140-6736(14)60611-5

P1433

P1476

Effects of intensive glycaemic ...... ised, controlled ACCORD trial.

@en

P2093

ACCORD Study Group

http://www.w3.org/2001/XMLSchema#string

Charlotte McDonald

http://www.w3.org/2001/XMLSchema#string

Faramarz Ismail-Beigi

http://www.w3.org/2001/XMLSchema#string

Gillian L Booth

http://www.w3.org/2001/XMLSchema#string

Joe Largay

http://www.w3.org/2001/XMLSchema#string

Michael E Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Effects of combination lipid therapy in type 2 diabetes mellitus.

Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

P304

1936-1941

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(14)60611-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

9958

http://www.w3.org/2001/XMLSchema#string

P478

384

http://www.w3.org/2001/XMLSchema#string

P50

Hertzel C. Gerstein

Heather A Lochnan

P577

2014-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25088437

http://www.w3.org/2001/XMLSchema#string

P932

4397008

http://www.w3.org/2001/XMLSchema#string